文献速递口腔黏膜病

扁平苔藓样黏膜炎不应忽视异型增生

Dysplasia Should Not Be Ignored in Lichenoid Mucositis.
PubMed 文献 · J Dent Res · 2018-01-12

该研究基于人群前瞻性队列(随访>10年)比较低级别异型增生伴或不伴扁平苔藓样黏膜炎(LM)的恶变率。446例患者中,373例(84%)为不伴LM的异型增生,73例(16%)为伴LM的异型增生;两组进展率分别为13%和8%(P=0.24),3年和5年进展率亦无差异(P=0.36)。结论:伴或不伴LM的异型增生癌变风险相似,存在LM时不应忽视异型增生。

要点

  • 伴LM的异型增生与不伴LM者恶变风险无显著差异。
  • 异型增生进展与不吸烟、高风险部位及中级别异型增生相关。
  • 临床遇LM时应仔细评估异型增生,不应因LM而低估风险。

核心结论

  • 伴或不伴LM的异型增生具有相似的癌变风险,存在LM时不应忽视异型增生。

研究设计与样本

  • 基于人群的前瞻性队列研究,随访超过10年,纳入446例原发低级别异型增生患者(446个病变)。

主要发现

  • 373例(84%)为不伴LM的异型增生,73例(16%)为伴LM的异型增生。
  • 3年和5年进展率两组无差异:不伴LM组6.7%和12.5%,伴LM组2.9%和6.6%(P=0.36)。
  • 进展与不吸烟、高风险部位及中级别异型增生诊断相关,与是否伴LM无关。

临床怎么用

  • 对扁平苔藓样黏膜炎患者应进行组织病理学评估以排除异型增生。
  • 伴LM的异型增生应按异型增生进行随访管理,不应因LM而降低警惕。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Oral lichen planus is categorized as a potentially malignant condition by the World Health Organization; however, some argue that only lichen planus with dysplasia have malignant potential. Many pathologists call lichen planus with dysplasia "dysplasia with lichenoid mucositis (LM)" or "LM with dysplasia." Previous research has shown that certain high-risk patterns of loss of heterozygosity (LOH) in dysplastic lesions are associated with significantly increased cancer risk. However, LM without dysplasia lacks such molecular patterns, supporting the hypothesis that LM, by itself, is not potentially malignant and that only those with dysplasia have malignant potential. To further investigate the premalignant nature of LM with dysplasia, this study compared the rate of malignant progression of dysplasia with LM with that of dysplasia without LM. Patients from a population-based prospective cohort study with >10 y of follow-up were analyzed. Study eligibility included a histological diagnosis of a primary low-grade dysplasia with or without LM. A total of 446 lesions in 446 patients met the selection criteria; 373 (84%) were classified as dysplasia without LM, while 73 (16%) were classified as dysplasia with LM. Demographic and habit information, clinical information, and outcome (progression) were compared between the 2 groups. Forty-nine of 373 cases of dysplasia (13%) progressed compared to 8% (6/73) of dysplasia with LM. However, the difference was not statistically different ( P = 0.24). The 3- and 5-y rate of progression did not differ between the groups (6.7% and 12.5% for dysplasia without LM and 2.9% and 6.6% for those with LM; P = 0.36). Progression was associated with nonsmoking, location at a high-risk site, and diagnosis of moderate dysplasia regardless of whether LM was present or not. Dysplasia with or without LM had similar cancer risk, and dysplasia should not be discounted in the presence of LM.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Rock LD, Laronde DM, Lin I, et al. Dysplasia Should Not Be Ignored in Lichenoid Mucositis. J Dent Res. 2018. PMID: 29328891. doi:10.1177/0022034517748639

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。